Trademark: 88375829
Status Date
Monday, November 7, 2022
Filing Date
Monday, April 8, 2019
Published for Opposition
Tuesday, August 6, 2019
Abandoned Date
Monday, November 7, 2022
5 Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives
The wording "PAZALVEN" has no meaning in a foreign language.
Nov 7, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Nov 7, 2022
Abandonment - No Use Statement Filed
Mar 31, 2022
Notice Of Approval Of Extension Request E-Mailed
Mar 30, 2022
Sou Extension 5 Granted
Mar 24, 2022
Sou Extension 5 Filed
Mar 30, 2022
Case Assigned To Intent To Use Paralegal
Mar 24, 2022
Sou Teas Extension Received
Sep 29, 2021
Notice Of Approval Of Extension Request E-Mailed
Sep 27, 2021
Sou Extension 4 Granted
Sep 27, 2021
Sou Extension 4 Filed
Sep 27, 2021
Sou Teas Extension Received
Mar 25, 2021
Notice Of Approval Of Extension Request E-Mailed
Mar 23, 2021
Sou Extension 3 Granted
Mar 23, 2021
Sou Extension 3 Filed
Mar 23, 2021
Sou Teas Extension Received
Sep 22, 2020
Notice Of Approval Of Extension Request E-Mailed
Sep 18, 2020
Sou Extension 2 Granted
Sep 18, 2020
Sou Extension 2 Filed
Sep 18, 2020
Sou Teas Extension Received
Mar 27, 2020
Notice Of Approval Of Extension Request E-Mailed
Mar 25, 2020
Sou Extension 1 Granted
Mar 25, 2020
Sou Extension 1 Filed
Mar 25, 2020
Sou Teas Extension Received
Oct 1, 2019
Noa E-Mailed - Sou Required From Applicant
Aug 6, 2019
Official Gazette Publication Confirmation E-Mailed
Aug 6, 2019
Published For Opposition
Jul 17, 2019
Notification Of Notice Of Publication E-Mailed
Jul 1, 2019
Assigned To Lie
Jun 21, 2019
Approved For Pub - Principal Register
Jun 21, 2019
Examiner's Amendment Entered
Jun 21, 2019
Notification Of Examiners Amendment E-Mailed
Jun 21, 2019
Examiners Amendment E-Mailed
Jun 21, 2019
Examiners Amendment -Written
Jun 18, 2019
Assigned To Examiner
Apr 24, 2019
New Application Office Supplied Data Entered
Apr 11, 2019
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
